Search Results

There are 5096 results for: content related to: Pathophysiology of multiple sclerosis and the place of teriflunomide

  1. Teriflunomide for multiple sclerosis

    Intervention Review

    The Cochrane Library

    Dian He, Zhu Xu, Shuai Dong, Hong Zhang, Hongyu Zhou, Lu Wang and Shihong Zhang

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD009882.pub2

  2. You have full text access to this OnlineOpen article
    Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: Involvement of impaired integrin activation and immunologic synapse formation

    Arthritis & Rheumatism

    Volume 52, Issue 9, September 2005, Pages: 2730–2739, Maximilian Zeyda, Marko Poglitsch, René Geyeregger, Josef S. Smolen, Gerhard J. Zlabinger, Walter H. Hörl, Werner Waldhäusl, Thomas M. Stulnig and Marcus D. Säemann

    Article first published online : 2 SEP 2005, DOI: 10.1002/art.21255

  3. New and emerging disease modifying therapies for multiple sclerosis

    Annals of the New York Academy of Sciences

    Volume 1247, Issue 1, January 2012, Pages: 117–137, Shiv Saidha, Christopher Eckstein and Peter A. Calabresi

    Article first published online : 6 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06272.x

  4. You have full text access to this OnlineOpen article
    Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study

    British Journal of Pharmacology

    Volume 166, Issue 4, June 2012, Pages: 1320–1332, C Balagué, M Pont, N Prats and N Godessart

    Article first published online : 17 MAY 2012, DOI: 10.1111/j.1476-5381.2012.01836.x

  5. You have free access to this content
    Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 359–372, N. Melzer and S. G. Meuth

    Article first published online : 4 FEB 2014, DOI: 10.1111/cei.12195

  6. You have free access to this content
    Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 397–407, P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve

    Article first published online : 4 FEB 2014, DOI: 10.1111/cei.12206

  7. Multiple Sclerosis Therapeutic Pipeline: Opportunities and Challenges

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 192–206, Stephen Krieger

    Article first published online : 21 MAR 2011, DOI: 10.1002/msj.20241

  8. You have free access to this content
    Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system

    Clinical & Experimental Immunology

    Volume 176, Issue 2, May 2014, Pages: 135–148, A. Salmen, R. Gold and A. Chan

    Article first published online : 9 APR 2014, DOI: 10.1111/cei.12258

  9. You have free access to this content
    Multiple sclerosis treatment and infectious issues: update 2013

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 425–438, A. Winkelmann, M. Loebermann, E. C. Reisinger and U. K. Zettl

    Article first published online : 4 FEB 2014, DOI: 10.1111/cei.12226

  10. Treatment Options for Multiple Sclerosis: Current and Emerging Therapies

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9, September 2010, Pages: 916–927, Dr. Kristen M. Gawronski, Dr. Michelle M. Rainka, Dr. Malti J. Patel and Dr. Francis M. Gengo

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.9.916

  11. You have free access to this content
    A changing treatment landscape for multiple sclerosis: challenges and opportunities

    Journal of Internal Medicine

    Volume 275, Issue 4, April 2014, Pages: 364–381, F. Piehl

    Article first published online : 16 MAR 2014, DOI: 10.1111/joim.12204

  12. You have free access to this content
    Established and novel disease-modifying treatments in multiple sclerosis

    Journal of Internal Medicine

    Volume 275, Issue 4, April 2014, Pages: 350–363, A. H. Cross and R. T. Naismith

    Article first published online : 11 MAR 2014, DOI: 10.1111/joim.12203

  13. You have free access to this content
    Current and future disease-modifying therapies in multiple sclerosis

    International Journal of Clinical Practice

    Volume 64, Issue 5, April 2010, Pages: 637–650, S. Y. Lim and C. S. Constantinescu

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1742-1241.2009.02261.x

  14. Multiple Sclerosis

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt081

  15. Leflunomide for cytomegalovirus: bench to bedside

    Transplant Infectious Disease

    Volume 14, Issue 2, April 2012, Pages: 111–120, B. Chacko and G.T. John

    Article first published online : 9 OCT 2011, DOI: 10.1111/j.1399-3062.2011.00682.x

  16. Leflunomide pharmacokinetics after single oral administration to dogs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 34, Issue 6, December 2011, Pages: 609–611, L. M. SINGER, L. A. COHN, C. R. REINERO and M. G. PAPICH

    Article first published online : 16 FEB 2011, DOI: 10.1111/j.1365-2885.2011.01275.x

  17. You have free access to this content
    ARA Oral Abstracts

    Internal Medicine Journal

    Volume 44, Issue S2, May 2014, Pages: 1–7,

    Article first published online : 16 APR 2014, DOI: 10.1111/imj.12424

  18. Neurotherapeutics in multiple sclerosis: Novel agents and emerging treatment strategies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 75, Issue 2, March/April 2008, Pages: 157–167, Tracy DeAngelis and Fred Lublin

    Article first published online : 23 MAY 2008, DOI: 10.1002/msj.20030

  19. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients

    Pediatric Transplantation

    Volume 14, Issue 1, February 2010, Pages: 145–150, Carlos E. Araya, Eduardo H. Garin, Richard E. Neiberger and Vikas R. Dharnidharka

    Article first published online : 31 MAR 2009, DOI: 10.1111/j.1399-3046.2009.01183.x

  20. Topics of the 29th European Committee for Treatment and Research in Multiple Sclerosis Congress in Copenhagen, Denmark, 2013

    Clinical and Experimental Neuroimmunology

    Volume 4, Issue 3, December 2013, Pages: 354–357, Toru Koda

    Article first published online : 20 DEC 2013, DOI: 10.1111/cen3.12075